- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kaufman joins AccuImage
MRI pioneer Leon Kaufman, Ph.D., has taken the helm of AccuImage Diagnostics. Kaufman joined the company as CEO in mid-February, leaving Toshiba amid that company's reorganization (SCAN 1/31/01). Kaufman in 1975 established one of the world's first MRI
MRI pioneer Leon Kaufman, Ph.D., has taken the helm of AccuImage Diagnostics. Kaufman joined the company as CEO in mid-February, leaving Toshiba amid that company's reorganization (SCAN 1/31/01). Kaufman in 1975 established one of the world's first MRI development programs at the University of California, San Francisco, a program successively supported by Pfizer, Diasonics, and Toshiba America, as well as the National Institutes of Health. After leaving UCSF in 1994, Kaufman spent six years as Toshiba's chief scientist and vice president of engineering. In his new position at AccuImage, Kaufman will focus on the development and marketing of 3-D visualization and networking technology.
2/28/01, Issue # 1504, page 4.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
